Chemomab Therapeutics Ltd. – NASDAQ:CMMB
Chemomab Therapeutics Ltd. stock price today
$1
-1.01
-50.27%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
Chemomab Therapeutics Ltd. stock price monthly change
+81.08%
month
Chemomab Therapeutics Ltd. stock price quarterly change
+81.08%
quarter
Chemomab Therapeutics Ltd. stock price yearly change
+279.32%
year
Chemomab Therapeutics Ltd. key metrics
Market Cap | 31.30M |
Enterprise value | 4.76M |
P/E | -0.66 |
EV/Sales | N/A |
EV/EBITDA | -0.17 |
Price/Sales | N/A |
Price/Book | 0.49 |
PEG ratio | N/A |
EPS | -1.61 |
Revenue | N/A |
EBITDA | -20.47M |
Income | -19.40M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChemomab Therapeutics Ltd. stock price history
Chemomab Therapeutics Ltd. stock forecast
Chemomab Therapeutics Ltd. financial statements
| Jun 2023 | 0 | -7.97M | |
|---|---|---|---|
| Sep 2023 | 0 | -4.06M | |
| Dec 2023 | 0 | -3.45M | |
| Mar 2024 | 0 | -3.91M |
| Dec 2023 | 0 | -3.45M | |
|---|---|---|---|
| Mar 2024 | 0 | -3.91M | |
| Sep 2025 | 0 | -142.07K | |
| Dec 2025 | 0 | -142.07K |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 28849000 | 6.85M | 23.77% |
|---|---|---|---|
| Sep 2023 | 23417641 | 5.37M | 22.95% |
| Dec 2023 | 22151131 | 5.15M | 23.27% |
| Mar 2024 | 18009124 | 4.67M | 25.98% |
| Jun 2023 | -7.48M | -4.26M | 1.36M |
|---|---|---|---|
| Sep 2023 | -5.12M | 3.91M | 5.74K |
| Dec 2023 | -3.90M | 1.85M | 2.14M |
| Mar 2024 | 0 | 0 | 0 |
Chemomab Therapeutics Ltd. alternative data
| Aug 2023 | 20 |
|---|---|
| Sep 2023 | 20 |
| Oct 2023 | 20 |
| Nov 2023 | 20 |
| Dec 2023 | 20 |
| Jan 2024 | 20 |
| Feb 2024 | 20 |
| Mar 2024 | 20 |
| Apr 2024 | 20 |
| May 2024 | 20 |
| Jun 2024 | 20 |
| Jul 2024 | 20 |
Chemomab Therapeutics Ltd. other data
0.02%
-1.43%
of CMMB is owned by hedge funds
35.47K
-3.27M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2022 | 11950 | 0 |
| May 2022 | 2433 | 0 |
| Nov 2022 | 0 | 584432 |
| Jan 2023 | 0 | 350700 |
| Quarter | Transcript |
|---|---|
| Q1 2023 14 May 2023 | Q1 2023 Earnings Call Transcript |
| Q3 2022 11 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 12 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 12 May 2022 | Q1 2022 Earnings Call Transcript |
-
What's the price of Chemomab Therapeutics Ltd. stock today?
One share of Chemomab Therapeutics Ltd. stock can currently be purchased for approximately $1.
-
When is Chemomab Therapeutics Ltd.'s next earnings date?
Unfortunately, Chemomab Therapeutics Ltd.'s (CMMB) next earnings date is currently unknown.
-
Does Chemomab Therapeutics Ltd. pay dividends?
No, Chemomab Therapeutics Ltd. does not pay dividends.
-
How much money does Chemomab Therapeutics Ltd. make?
Chemomab Therapeutics Ltd. has a market capitalization of 31.30M.
-
What is Chemomab Therapeutics Ltd.'s stock symbol?
Chemomab Therapeutics Ltd. is traded on the NASDAQ under the ticker symbol "CMMB".
-
What is Chemomab Therapeutics Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Chemomab Therapeutics Ltd.?
Shares of Chemomab Therapeutics Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Chemomab Therapeutics Ltd. have?
As Jul 2024, Chemomab Therapeutics Ltd. employs 20 workers.
-
When Chemomab Therapeutics Ltd. went public?
Chemomab Therapeutics Ltd. is publicly traded company for more then 6 years since IPO on 12 Feb 2019.
-
What is Chemomab Therapeutics Ltd.'s official website?
The official website for Chemomab Therapeutics Ltd. is chemomab.com.
-
How can i contact Chemomab Therapeutics Ltd.?
Chemomab Therapeutics Ltd. can be reached via phone at +972 77 331 0156.
Chemomab Therapeutics Ltd. company profile:
Chemomab Therapeutics Ltd.
chemomab.comExchange:
NASDAQ
Full time employees:
20
Industry:
Biotechnology
Sector:
Healthcare
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
Building 7
Tel Aviv, 6158002
Tel Aviv, 6158002
CIK: 0001534248
ISIN: US16385C1045
CUSIP: 03280X102
